Palliative and end-of-life care
Pharmacists and pharmacy teams are vital part of the support network for patients and their families managing a terminal illness. In every healthcare setting, pharmacists can offer a wealth of information on the safe and effective use of their palliative medicines, ensuring patients can have the best quality of life in their last days.
The Pharmaceutical Journal is currently calling for ideas for blogs, comment pieces, educational support or research from all sectors of pharmacy that relate to palliative and end-of-life care. Find out more information here.
Please email us with a brief description of any initiative you are involved in that is aimed to improve access to palliative and end-of-life care or ideas for practical educational materials at: editor@pharmaceutical-journal.com
Features, opinion & podcasts
PJ view: Restore pharmacy opening hours to improve end-of-life care
How palliative care pharmacists in community practice are improving access to medicines
Controlled drug stock licensing is working against high-quality palliative care for care home patients
Effective deprescribing: getting the most from medicine
Learning
Opioid use in palliative care: selection, initiation and optimisation
Caring for palliative care patients at home: medicines management principles and considerations
Case-based learning: palliative and end-of-life care in community pharmacy
Palliative management in end-stage liver disease
Facilitating anticipatory prescribing in end-of-life care
Communicating with palliative care patients nearing the end of life, their families and carers
New priorities for palliative care
The Royal Pharmaceutical Society (RPS) and the UK’s leading end-of-life charity Marie Curie have developed eight ‘Daffodil Standards’ for palliative and end-of-life care, aimed to improve the care provided to patients approaching the end of their life through community pharmacy.
Further policy information developed by RPS Wales around palliative and end-of-life care can be found here.